Satyam update: CLB Says: Company law board okays Satyam stake sale plan. Authorize hike in Satyam capital base to Rs 280 crore. Authorize preferential allotment of equity shares. Preferential allotment to be made at par or at premium. Clears open competitive price bidding for strategic partner. To issue another 60 crore shares at Rs 2 face value
Satyam update: -Satyam likely to sell 26% stake to strategic partner. -Satyam in favour of subsequent open offer of 20% by acquirer: -Investment bankers say 12 companies have evinced verbal interest: -SEBI to change preferential allotment norms in line with new takeover norms: -Government may ask board to fast track restatement of accounts.
Areva T&D: R1: 191.8, R2: 195.6, R3: 199.2, S1: 184.3, S2: 180.7, S3: 176.9
Areva T&D bags orders worth Rs 200 cr
Cipla: R1: 194, R2: 196.1, R3: 197.7, S1: 190.4, S2: 188.8, S3: 186.7
Bayer-Cipla case over Nexavar adjourned till February 25 ((Nexavar used for treatment of kidney & liver cancer))
IFCI still holds Rs 100 crore worth of shares pledged by Unitech. Unitech has to repay Rs 50 crore to IFCI in June.
IOL Netcom board approves preferential issue of up to Rs 150 crore
Industry News:
Another stimulus package possible: Pranab Mukherjee
SEBI to amend norms on pricing of preferential issue: BL
No comments:
Post a Comment